(Q75231218)
Statements
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes (English)
Stadler M
Germing U
Kliche KO
Josten KM
Kuse R
Hofmann WK
Schrezenmeier H
Novotny J
Anders O
Eimermacher H
Verbeek W
Kreipe HH
Heimpel H
Aul C